Research Study in Patients With Severe Ulcerative Colitis
Completed · Phase 2/Phase 3
Conditions studied: Ulcerative Colitis
In brief
The purpose of the study is to evaluate an intravenous (by injection) investigational medication to treat severe ulcerative colitis refractory to steroid therapy. The research is being conducted at up to 8 clinical research sites in the US and is open to both men and women ages 18 to 70 years old. Participants in the study will have a number of visits to a research site. All study-related care and medication is provided to qualified participants at no cost: this includes all visits, examinations and laboratory work.
Key facts
- Study ID
- NCT00032305
- Run by
- Facet Biotech
- People needed
- 20
- Starts
- 2002-03-01
- Expected to finish
- 2005-11-01
- Last updated by the study team
- 2012-03-07
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- University of California — San Francisco, California, United States
- Atlanta Gastroenterology Associates — Atlanta, Georgia, United States
- The University of Chicago Medical Center — Chicago, Illinois, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Mount Sinai School of Medicine — New York, New York, United States
- University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.